“全球化是必答题，不是选择题。”10月30日，由《证券日报》社主办的“大国新药价值重构——2026大健康产业大会”在杭州举行。在以“资本赋能创新医药——从估值到价值的突围”为主题的圆桌论坛环节，北京诺诚健华医药科技有限公司（以下简称“诺诚健华”）企业传播执行总监陆春华围绕创新药企从研发价值走向商业价值、从国内市场走向全球舞台的路径分享了经验与判断。 诺诚健华于2015年伴随着中国创新药元年诞生，...
Source Link“全球化是必答题，不是选择题。”10月30日，由《证券日报》社主办的“大国新药价值重构——2026大健康产业大会”在杭州举行。在以“资本赋能创新医药——从估值到价值的突围”为主题的圆桌论坛环节，北京诺诚健华医药科技有限公司（以下简称“诺诚健华”）企业传播执行总监陆春华围绕创新药企从研发价值走向商业价值、从国内市场走向全球舞台的路径分享了经验与判断。 诺诚健华于2015年伴随着中国创新药元年诞生，...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.